This finding highlights that cognition is best predicted by diagnostic status (which occurs because cognitive performance partially defines diagnostic status) and that tau does not provide much additional information beyond diagnostic group when predicting cognition across the aging and AD clinical spectrum. The gene discussed is MAPT; the disease is Alzheimer disease.